Cargando…
Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
Changes in pH can alter the uptake of chemotherapy drugs. Proton pump inhibitors (PPIs) may therefore increase the chemosensitivity of cancer cells and cytotoxicity of chemotherapeutic drugs by increasing their uptake. We investigated the chemosensitizing potential of PPIs in colorectal cancer (CRC)...
Autores principales: | Wang, Xiaoyu, Liu, Chun, Wang, Jiaqi, Fan, Yue, Wang, Zhenghua, Wang, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601694/ https://www.ncbi.nlm.nih.gov/pubmed/28938598 http://dx.doi.org/10.18632/oncotarget.18522 |
Ejemplares similares
-
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
por: Ferrari, Stefano, et al.
Publicado: (2013) -
Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway
por: Wang, Xiaoyu, et al.
Publicado: (2017) -
Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020) -
Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase
por: Zeng, Xiaoyu, et al.
Publicado: (2016) -
Proton pump inhibitors and colorectal cancer: A systematic review
por: Patel, Agastya, et al.
Publicado: (2021)